Newsroom
Sorted by: Latest
-
Special Screening of “Everest: The Other Side” Monday, October 26 at New York’s IMAX Lincoln Square
--(BUSINESS WIRE)--The Walt Disney Company: WHAT: A special screening of “Everest: The Other Side,” an intimate portrait of two people bound by love, ambition, and the pursuit of the impossible, from National Geographic Documentary Films and Oscar®-winning filmmakers Elizabeth Chai Vasarhelyi and Jimmy Chin. A thrilling cinematic experience chronicling one of the most dangerous climbs imaginable, the film will open exclusively in theaters and IMAX® worldwide October 30. WHO: From the Film: Ji...
-
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
GENEVA--(BUSINESS WIRE)--Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2...
-
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
GENEVA--(BUSINESS WIRE)--Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2...
-
Darling Ingredients Introduces Nextida® NxCogni™, the First Targeted Collagen Peptide Designed to Support Clarity and Cognitive Resilience
IRVING, Texas--(BUSINESS WIRE)--Darling Ingredients Inc. (NYSE: DAR) and its premier health brand Rousselot today introduced Nextida NxCogni, the first targeted collagen peptide ingredient formulated to support clarity and cognitive resilience. Built on the company's Nextida platform, Nextida NxCogni is a non-stimulant collagen peptide ingredient that targets neurosupportive benefits for use in dietary supplements. “NxCogni is the latest example of how Darling Ingredients is redefining what col...
-
TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard-of-care therapies and an investigational immunotherapeutic to transform outcomes for patients with solid tumors, today announced that it will host a conference call and webcast on Tuesday, November 10, 2026, at 8:30 AM eastern time to discuss its financial results for the quarter ended September 30, 2026. A press release detail...
-
Johnson & Johnson تستعرض مستقبل الذكاء الجراحي خلال قمة مستقبل الصحة في أبوظبي 2026
أبوظبي، الإمارات العربية المتحدة--(BUSINESS WIRE)--تستعرض Johnson & Johnson تقنيات الجراحة الرقمية وتعاونها الاستراتيجي مع دائرة الصحة – أبوظبي (DOH)، بهدف الارتقاء بمستويات الذكاء الجراحي، وذلك خلال قمة مستقبل الصحة في أبوظبي 2026. وتأتي مشاركتها في هذه القمة التي تجمع نخبة من قادة قطاعات الرعاية الصحية والحكومة والتكنولوجيا والبحث العلمي والاستثمار، بهدف تسريع وتيرة الابتكار الصحي التحويلي. تماشيًا مع شعار القمة لهذا العام، "من الاستشعار إلى التنبؤ"، يجسّد هذا التعاون طموحًا مشتركًا لتوظيف...
-
The Toro Company Names Neal M. Lackritz Chief Technology Officer
BLOOMINGTON, Minn.--(BUSINESS WIRE)--Neal Lackritz will lead The Toro Company’s enterprise technology strategy with responsibility for accelerating breakthrough innovations....
-
Sallie Mae Declares Dividends on Preferred Stock Series B and Common Stock
NEWARK, Del.--(BUSINESS WIRE)--Sallie Mae® (Nasdaq: SLM), formally SLM Corporation, today announced a 2026 fourth-quarter dividend on its Preferred Stock Series B of $1.4939647 per share. The company also announced a 2026 fourth-quarter dividend on its common stock of $0.13 per share.Both preferred stock and common stock dividends will be paid on Dec. 15, 2026, to the respective stockholders of record at the close of business on Dec. 4, 2026.Sallie Mae (Nasdaq: SLM) believes education and life-l...
-
Northern Trust Declares Quarterly Dividends on Common and Preferred Stock
CHICAGO--(BUSINESS WIRE)--Northern Trust Corporation declared quarterly cash dividends and announced a new common stock repurchase authorization....
-
Claros Mortgage Trust, Inc. Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
NEW YORK--(BUSINESS WIRE)--Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today announced that it will release its third quarter 2026 financial results after the closing of trading on the New York Stock Exchange on Tuesday, November 3, 2026. A conference call to discuss CMTG’s financial results will be held on Wednesday, November 4, 2026, at 10:00 a.m. ET. The conference call may be accessed by dialing 1-833-461-5787 and referencing the Claros Mortgage Trust, Inc. teleconfer...